Keywords: new, indication, acular, allergan, inc, received, regulatory

New Indication For Acular

Article | 13 January 1997

Print This

Allergan Inc has received US regulatory approval to market its Acular(ketorolac tromethamine ophthalmic solution) 0.5% in the USA for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in